Stockscreener 앱 받기
1.45
9.09%
0.1208
시간 외 거래:
1.43
-0.02
-1.38%
Enveric Biosciences Inc (ENVB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
6,700%
-0.000132
|
0.000002 | -0.000225 | -0.000217 | -0.000035 |
Operating Expenses
|
15.15%
2.5189
|
2.1875 | 3.1736 | 2.083 | 1.8979 |
| Benefits Costs and Expenses |
15.29%
2.519
|
2.185 | 3.1472 | 2.0838 | 1.8794 |
| Costs And Expenses |
15.29%
2.519
|
2.185 | 3.1472 | 2.0838 | 1.8794 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Depreciation and Amortization |
50.66%
0.04
|
0.081 | 0.0825 | 0.0848 | 0.0848 |
| Operating Income/Loss |
15.15%
-2.519
|
-2.1875 | -3.1738 | -2.0832 | -1.8979 |
| Net Interest Income/Expense |
6,700%
-0.000132
|
0.000002 | -0.000225 | -0.000217 | -0.000035 |
| Nonoperating Income/Loss |
105.14%
-0.000132
|
0.00257 | 0.0264 | -0.00084 | 0.0185 |
| Income/Loss From Continuing Operations Before Tax |
15.30%
-2.5192
|
-2.185 | -3.1474 | -2.084 | -1.8794 |
| Income/Loss From Continuing Operations After Tax |
15.30%
-2.5192
|
-2.185 | -3.1564 | -2.084 | -1.8794 |
|
Net Income/Loss
|
15.30%
-2.5192
|
-2.185 | -3.1546 | -2.084 | -1.8794 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
44.39%
2.5957
|
1.7978 | -6.2683 | 8.703 | 7.5879 |
| Diluted Average Shares |
44.39%
2.5957
|
1.7978 | -6.2683 | 8.703 | 7.5879 |
| Basic Earnings Per Share |
20.49%
-0.97
|
-1.22 | -18.09 | -0.24 | -0.25 |
| Diluted Earnings Per Share |
20.49%
-0.97
|
-1.22 | -18.09 | -0.24 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.98%
8.06%
자본화:
|
볼륨(24시간):